Growth-hormone secretagogues: mechanism is not a clinical outcome

Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.

Growth-hormone secretagogue claims often begin with a biological pathway or a short-term laboratory measurement. Neither one establishes a meaningful health, performance, or recovery benefit. FDA has identified potential significant safety risks for several bulk substances in this category; review the FDA's current bulk-substances information for product-specific context.